32581766|t|Telmisartan and Rosuvastatin Synergistically Ameliorate Dementia and Cognitive Impairment in Older Hypertensive Patients With Apolipoprotein E Genotype.
32581766|a|Objective: To investigate the effect of telmisartan, rosuvastatin, or their combination on dementia and to understand the impact of apolipoprotein E (APOE) genotype on the effect of the medications in older patients with hypertension. Methods: This is a double-blind, randomized, and placebo-controlled trial using a 2 x 2 factorial design. Between April 2008 and November 2010, 1,244 hypertensive patients aged >=60 years without cognitive impairment were recruited from communities in six cities in Shandong area, China. Patients were randomized into telmisartan and rosuvastatin administration after a 2-week washout period. APOE genotype was identified at the baseline. Possible dementia was determined using the combination of the global cognitive function and Assessment of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Results: Over an average follow-up of 7 [interquartile range (IQR): 6.7-7.2] years, telmisartan and rosuvastatin significantly reduced the cognitive impairment progression and the incidence of dementia. There was a synergistic interaction between telmisartan and rosuvastatin to reduce the cognitive impairment and the incidence of dementia (P adjusted < 0.001). The cognitive impairment progression and the risk of dementia were higher in the hypertensive patients with APOE epsilon4 allele than in those without APOE epsilon4 allele. Rosuvastatin medication significantly alleviated the cognitive impairment progression and the risks of dementia in patients with APOE epsilon4 allele. Conclusion: The combination of telmisartan and rosuvastatin might be an effective prevention and/or treatment strategy for cognitive impairment and dementia, especially in hypertensive patients with the APOE epsilon4 allele. Clinical Trial Registration: www.ClinicalTrials.gov, ChiCTR.org.cn, identifier ChiCTR-IOR-17013557. Registered on April 12, 2017 - Retrospectively registered, http://www.chictr.org.cn/showproj.aspx?proj=23121.
32581766	0	11	Telmisartan	Chemical	MESH:D000077333
32581766	16	28	Rosuvastatin	Chemical	MESH:D000068718
32581766	56	64	Dementia	Disease	MESH:D003704
32581766	69	89	Cognitive Impairment	Disease	MESH:D003072
32581766	99	111	Hypertensive	Disease	MESH:D006973
32581766	112	120	Patients	Species	9606
32581766	126	142	Apolipoprotein E	Gene	348
32581766	193	204	telmisartan	Chemical	MESH:D000077333
32581766	206	218	rosuvastatin	Chemical	MESH:D000068718
32581766	244	252	dementia	Disease	MESH:D003704
32581766	285	301	apolipoprotein E	Gene	348
32581766	303	307	APOE	Gene	348
32581766	360	368	patients	Species	9606
32581766	374	386	hypertension	Disease	MESH:D006973
32581766	538	550	hypertensive	Disease	MESH:D006973
32581766	551	559	patients	Species	9606
32581766	584	604	cognitive impairment	Disease	MESH:D003072
32581766	676	684	Patients	Species	9606
32581766	706	717	telmisartan	Chemical	MESH:D000077333
32581766	722	734	rosuvastatin	Chemical	MESH:D000068718
32581766	781	785	APOE	Gene	348
32581766	836	844	dementia	Disease	MESH:D003704
32581766	1091	1102	telmisartan	Chemical	MESH:D000077333
32581766	1107	1119	rosuvastatin	Chemical	MESH:D000068718
32581766	1146	1166	cognitive impairment	Disease	MESH:D003072
32581766	1200	1208	dementia	Disease	MESH:D003704
32581766	1254	1265	telmisartan	Chemical	MESH:D000077333
32581766	1270	1282	rosuvastatin	Chemical	MESH:D000068718
32581766	1297	1317	cognitive impairment	Disease	MESH:D003072
32581766	1339	1347	dementia	Disease	MESH:D003704
32581766	1374	1394	cognitive impairment	Disease	MESH:D003072
32581766	1423	1431	dementia	Disease	MESH:D003704
32581766	1451	1463	hypertensive	Disease	MESH:D006973
32581766	1464	1472	patients	Species	9606
32581766	1478	1482	APOE	Gene	348
32581766	1521	1525	APOE	Gene	348
32581766	1543	1555	Rosuvastatin	Chemical	MESH:D000068718
32581766	1596	1616	cognitive impairment	Disease	MESH:D003072
32581766	1646	1654	dementia	Disease	MESH:D003704
32581766	1658	1666	patients	Species	9606
32581766	1672	1676	APOE	Gene	348
32581766	1725	1736	telmisartan	Chemical	MESH:D000077333
32581766	1741	1753	rosuvastatin	Chemical	MESH:D000068718
32581766	1817	1837	cognitive impairment	Disease	MESH:D003072
32581766	1842	1850	dementia	Disease	MESH:D003704
32581766	1866	1878	hypertensive	Disease	MESH:D006973
32581766	1879	1887	patients	Species	9606
32581766	1897	1901	APOE	Gene	348
32581766	Negative_Correlation	MESH:D000068718	MESH:D006973
32581766	Negative_Correlation	MESH:D000068718	MESH:D003072
32581766	Negative_Correlation	MESH:D000077333	MESH:D003072
32581766	Negative_Correlation	MESH:D000068718	MESH:D003704
32581766	Association	MESH:D006973	348
32581766	Cotreatment	MESH:D000068718	MESH:D000077333
32581766	Negative_Correlation	MESH:D000077333	MESH:D006973
32581766	Negative_Correlation	MESH:D000077333	MESH:D003704
32581766	Association	MESH:D003704	348
32581766	Association	MESH:D000077333	348
32581766	Association	MESH:D003072	348
32581766	Association	MESH:D000068718	348

